Watch Demo

The United Kingdom Antidiabetics Industry Outlook 2024 - 2028

See how the United Kingdom Antidiabetics performed compared to key markets.

Key Market Indicators

British insulin imports are projected to soar to approximately $510 million by 2028, up from nearly $487 million in 2023. This marks a steady annual growth rate of 0.6%. Over the past 25 years, the demand for insulin in the UK has increased by an average of 0.7% each year. On the export front, the UK's insulin export market is expected to reach around $84 million by 2028, rising from $74 million in 2023. This represents an annual growth rate of 1.9%. Since 1998, British insulin exports have seen a more robust average annual increase of 3.1%. In 2023, the UK ranked ninth in the global insulin export market. Belgium surpassed the UK with exports valued at $74 million. The top three positions were held by France, Italy, and China.

Marketing Banner

The United Kingdom Antidiabetics Market Data and Forecasts

What is the size of the British Antidiabetics Market in 2024?

Insulin in Dosage Market Size Value in the UK
Insulin in Dosage Market Size Value Per Capita in the UK
More in Antidiabetics Industry in major countries

How much will the United Kingdom Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in the UK
Forecast: Import of Insulin in Dosage Forms to the UK
Forecast: Export of Insulin in Dosage Forms from the UK
Forecast: Import of Insulin in Dosage Forms to the UK
More in Antidiabetics Industry for 2028